SAN FRANCISCO@JPM

12-15 Jan |

Book your meeting

A Clearer Picture of Future Outcomes  

↳ predictions beyond standard of care

4(3D+tIME) GENAI FOR PRECISION MEDICINE

Medical images detect diseases. What if they helped clinicians look ahead too? 

Our latest conference contribution

For which patients can a new therapy improve outcomes?

STANDARD CARE
Tumor persists
AI: +6 months
NEW THERAPY
Complete response
AI: +6 months

Same patient, different therapies.

STARTING WITH BREAST CANCER - WE NEED TO CHANGE THESE STATISTICS

Hundreds of thousands of patients are waiting on clinical uptake of new therapies

Even 10% faster clinical uptake has a massive impact

+0 patients

could be treated earlier with 10% faster access

+0 survivors

with 10% faster clinical uptake

+0 years

from approval to peak sales

Cancer4D: Beyond standard of care 

what WE can do

Why not an LLM? Precision medicine requires reproducible predictions - with an LLM the same prompt give different results.

Clinicians say the 4D GenAI technology is a seismic shift

Fully embedded into existing research infrastucture, for curated data and feedback from 300 healthcare providers

We trained Cancer4D with breast and brain images, and are extending our capabilities to lung and prostate

Learn more for

Healthcare providers, pharma companies and regulatory authorities

Go to our pages with more information
Article

Regulatory innovation for 4D generative AI

8. December 2025
>> Read more
Article

Validation of oncology virtual Phase III trials

10. December 2025
>> Read more
Article

4D generative AI in regulatory terms for EMA

11. December 2025
>> Read more

“As a young woman, the risks of breast and interval cancer can be worrying. However, knowing that Aileen Health enables radiologists to not only detect breast cancer but also evaluate future risks of interval cancer gives me peace of mind. The thorough approach to early detection and prevention helps me feel more confident and reassured about the health of my family, friends and myself.”

Matilda Åboge Eriksson
Woman

This is a wonderful product, especially for younger women in high risk groups, who wants to wait with medical procedures until the children are born.

Liza
Patient advocate

It is a great relief for women to hear that there are no signs of cancer for the next 2 years. Especially for women with a family history of cancer.

Mary
Breast radiologist

TESTIMONIALS

Ai:leen Health started from conversations with women

Together with providers and pharma, we can make sure women stop dying from the disease.

OUR TEAM

Scientific, technical, and business

Our team has decades of experience in AI and working with healthcare systems

Contact us now

Our next stops

Meet us in person when we are on the road

 We’d love to meet you in person!

  1. 05 Feb, 26 - 06 Feb, 26

    Munich, Germany

    DxPx Europe

Get notified when we have more news

Together, we can revolutionize healthcare. Subscribe to our updates and be the first to know when and where Ai:leen is available.

Newsletter

You are about to download our 2025 ESMO AI poster “Predicting solid-tumor behaviour over time with explainable gen AI for precision oncology”

By submitting this form, you agree to our privacy policy